Cerebrovascular Disease Diagnosis and Treatment Center
By the end of 2018 the Cerebrovascular Disease Treatment Center had 155 medical, nursing and technical staff, including two postdoctoral fellows, 21 doctoral and 39 master's graduates. It comprised seven neurology wards, separate neurology outpatient and emergency services, and a neurophysiology department. It chaired the stroke prevention and control committee of the Liaoning Preventive Medicine Association and the Liaoning Primary Health Work Association, was a provincial key specialty and the Shenyang Stroke Clinical Medical Research Center, among the first National Health and Family Planning Commission stroke-screening base hospitals in Liaoning and a China cardiogenic stroke prevention and treatment base hospital, and chaired the provincial cardiovascular and cerebrovascular disease prevention and treatment guidance group.
Its techniques, described as nationally leading, included ultra-early intravenous and intra-arterial thrombolysis and thrombectomy for cerebral infarction; carotid Doppler ultrasound combined with transcranial Doppler (TCD) to screen high-risk patients; TCD bubble testing in young stroke and migraine patients; standardized cerebrovascular disease and headache care; cerebral angiography and intracranial and extracranial stents for ischemic cerebrovascular disease; clinical and imaging assessment of cerebral small vessel disease; dementia scales and imaging for differential diagnosis; and community screening of high-risk people.
New techniques: Neurology I: intracranial arterial thrombectomy (2014), polysomnography and prolonged ambulatory ECG (both 2018), Chen Xin. Neurology II: endovascular treatment, emergency and elective arterial thrombectomy (2015), Wang Jian. Neurology IV: botulinum toxin injections (November 2016), Ren Zhanxiu.
Research awards, Neurology IV: Basic and clinical research on migraine mechanisms, provincial science and technology progress third prize (2009); research on inflammatory migraine mechanisms and prevention and treatment strategies, Shenyang science and technology progress first prize (2015); and Stroke Prevention, Treatment and Rehabilitation, Liaoning Medical Science and Technology Award (2015). He Qiu ranked first in each.
International exchange: In 2010 Ju Naixin, a female chief physician in Neurology III, participated in the final report meeting and final report on the Cardiorenal Protection Study at the University of Oxford, United Kingdom. Source: hospital chronicle, 2010–2019 edition.
Official department pageSource checked
Doctors
Doctor profiles: 35
仇建婷
Associate Chief Physician
Clinical interests
Prevention and treatment of risk factors for cerebrovascular disease; proficient in the diagnosis and treatment of dizziness, headache, dementia, epilepsy, Parkinson’s disease, multiple sclerosis, peripheral neuropathy, and central nervous system infections.
任占秀
Associate Chief Physician
Clinical interests
Standardized diagnosis and treatment of primary headaches, medication-overuse headache, and chronic migraine; botulinum toxin treatment for chronic migraine, hemifacial spasm, Meige syndrome, and other movement disorders.
何秋
Chief Physician